万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生>>康复医学

Oncology(研究方向:肿瘤学) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Oncology(双月刊),创刊于1967年,出版国家为瑞士,是国际癌症研究与治疗杂志。这本杂志的作用是进一步翻译实验成果应用于临床,并再回到实验室进一步调查。这项工作的根本目的是促进临床相关的癌症知识,并改善预防,诊断和治疗恶性疾病的结果。该杂志发表了来自世界各地癌症计划的重要临床研究,以及重要的翻译实验室研究结果,短评(邀请并提交)以及对肿瘤学领域不断发展和有争议的主题的深入讨论。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://www.karger.com/Journal/Home/223857

3、期刊投稿:

http://xpresstrackcloud.net/karger/xpresstrack/submissions/author_login.cfm?jid=107

4、官网电话:+41 61 306 1359

5、官网邮箱:ocl@karger.com

6、编辑部地址:Editorial Office 'Oncology', S. Karger AG, P.O. Box, CH-4009 Basel (Switzerland)

7、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017214日星期二

                     

 

Instructions for Authors

 

Submission

 

Original papers and reviews written in English are considered for publication. Manuscripts should be submitted to 'Oncology' online and must be accompanied by a cover letter signed by the submitting/corresponding author on behalf of all co-authors. Assurance should be given that the manuscript is not under simultaneous consideration by any other publication.

For specific instructions on how to prepare a manuscript for submission please visit:

 

Online Manuscript Submission

 

Names, postal and e-mail addresses of at least four experts in the appropriate area of research must accompany each manuscript. Selected scientists will be invited to act as referees. Referees suggested should not be from the same institution as the author and should have expert knowledge of the subject.

 

Should you have any problems with your submission, please contact:

 

Dr. Maurie Markman, MD

S. Karger AG

Editorial Office 'Oncology'

P.O. Box

CH–4009 Basel (Switzerland)

Tel. +41 61 306 1359

Fax    +41 61 306 1434

E-Mail ocl@karger.com

 

Mailing address for courier deliveries only:

Allschwilerstrasse 10

CH–4055 Basel (Switzerland)

 

Categories of Manuscripts

 

Reviews are comprehensive, state-of-the-art analyses and investigations of important clinical problems. Reviews must include a critical discussion of the reported data and give a clear conclusion with the potential impacts on the standart of care. Reviews may be invited by the Editor, or they may be unsolicited submissions. Reviews are not subject to page charges. The maximum length of manuscripts in this category will be 5,000 words for text and tables (a table = 250 words, per page), with a maximum of 5 tables and 50 references.

 

Clinical Studies and Clinical Translational Research Articles are full-length research papers which will be considered for the journal. These articles cover topics relevant to clinical and translational studies in all oncological fields. Note that manuscripts presenting laboratory-based research efforts must address a clinically relevant issue (Translational Research).

 

Short Communications will focus on descriptions of important toxicities of novel therapies and highly unique oncology-related medical management issues. The maximum length of manuscripts in this category will be 1,000 words.

 

Clinical Trial Notes are designed for brief discussions of clinical trials, with a particular focus on phase 1, phase 1/2, and phase 2 studies. Priority in this section will not be for studies with a ‘positive result’, but rather for well-conceived and conducted clinical research efforts. The maximum length of manuscripts submitted in this category will be 1,500 words, with a maximum of 2 tables and 1 figure. The paper should be divided into four sections: Introduction, Methods, Results, Discussion. Note that all manuscripts submitted in this category will undergo rapid review for acceptance or rejection.

 

Reducing the Worldwide Burden of Cancer are country reports describing a variety of regional, national or international efforts that focus on the unique aspects of the epidemiology of cancer, and the delivery of educational messages, preventive services, and oncology-related care within the developing world. Papers submitted for this section benefit from a higher quota of free pages. There are no page charges for papers of 8 or fewer printed pages. Each additional complete or partial page is charged to the author at CHF 325.00.

 

Editorials are commentaries on current topics or on papers published elsewhere in the issue. Word count limit is 1500 and 10 references are allowed. They are usually invited by the Editor.

 

Letters addressed to the Editor are encouraged if they directly concern articles previously published in this journal and clinical subjects related to the matters discussed. The editor reserves the right to submit copies of such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal. But letters on general scientific or medical subjects in oncology are also welcome. The length should not exceed 500 words.

 

Arrangement

 

Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.

 

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

 

Key words: Please supply 3–10 key words in English that reflect the content of the paper.

 

Abstract: Papers submitted to the sections Reviews, Clinical Studies, Clinical Translational Research Articles, Clinical Trial Notes and Reducing the Worldwide Burden of Cancer need an abstract of up to 200 words. Abstracts are recommended, but optional, for Short Communications and Editorials. Abstracts of papers submitted for publication that have clinical implications using human materials should be structured with subheadings as follows: Objective(s), Methods, Results, Conclusion(s).

 

Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

 

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Each illustration must be labelled with its number and the first author's name.

B/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. Figure files must not be embedded in a document file but submitted separately (see also the detailed Online Submission Instructions).

 

编辑委员会

 

主编辑

M. Markman,费城,宾夕法尼亚州。

 

区域编辑日本

O.Hino,东京

 

编委会

AB本森,芝加哥,伊利诺伊州

A.昌,新加坡

AL程,台北

JF克利里,麦迪逊威斯康星州

M. Dietel,柏林

P.杜福尔,斯特拉斯堡

MS Ernstoff,纽约州布法罗

M. Fakih,杜阿尔特,加利福尼亚州

JJ Grau,巴塞罗那

H. GronemeyerIllkirch

DF HayesAnn ArborMichCS

JohnsonBuffaloNY

MJ KelleyDurhamNC L.Kumar

New Delhi

PJ LoehrerIndianapolisInd.JM

MarshallBuffaloNY

S. Monfardini Milan R.Nagler

Haifa R.Ohno

Nagoya

B. PestalozziZurich

HM PinedoAmsterdam

E. RepaskyBuffaloNY D.Santini

Rome

A.SimczukLublin

EF SmithAmsterdam

CN SternbergRome

R.Stupp Zurich

MS TallmanNew YorkNY

S. TanakaHiroshima

M. TianHouston TexDL

TrumpBuffaloNY

T. WiegelUlm

W. YasuiHiroshima

H. ZhangHangzhou City

 

JSGC编辑代表

M.上西,东京

K.今井,东京

W.安井,广岛